Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zealand Pharma Director's Dealing 2017

Apr 6, 2017

3391_rns_2017-04-06_726f1c52-0750-4aa6-a273-26a36151591c.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

FINANSTILSYNET

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Adam Steensberg
2. Reason for the notification
a) Position/status Senior Vice President, Chief Medical and Development Officer in Zealand Pharma A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Zealand Pharma A/S, CVR-no. 20045078
b) LEI1 549300ITBB1ULBL4CZ12
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code Warrants
DK0060257814
b) Nature of the transaction Grant of warrants
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 41.92 57,000
d) Aggregated information
- Aggregated volume
- Price DKK 2,389,440.00
e) Date of the transaction 06-04-2017
f) Place of the transaction Outside a trading venue